Jordan vs Lao People's Democratic Republic: Share of E. coli infections resistant to cephalosporins
Jordan
57.2%
in 2022
Lao People's Democratic Republic
52.6%
in 2022
Jordan rank
14th
Lao People's Democratic Republic rank
16th
Share of E. coli infections resistant to cephalosporins over time
- Jordan
- Lao People's Democratic Republic
How they compare
Jordan currently reports 57.2% against 52.6% in Lao People's Democratic Republic, a difference of 4.6%.
That makes Jordan's figure about 1.1 times Lao People's Democratic Republic's.
Across all 5 years both countries report, Jordan has been ahead every year.
Jordan ranks 14th and Lao People's Democratic Republic ranks 16th of 46 countries.
Jordan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jordan | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 64.3% | 47.7% | 16.6% | Jordan |
| 2020s | 60.7% | 49.7% | 11.1% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Jordan or Lao People's Democratic Republic?
- Jordan, at 57.2% against 52.6% in Lao People's Democratic Republic as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Jordan and Lao People's Democratic Republic?
- 4.6%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Lao People's Democratic Republic?
- 5 years are reported by both, from 2018 to 2022.
- How do Jordan and Lao People's Democratic Republic rank globally for share of e. coli infections resistant to cephalosporins?
- Jordan ranks 14th and Lao People's Democratic Republic ranks 16th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).